BioMarin Pharmaceutical | Umlaufvermögen



Current Assets Veränderung Datum
Acadia Pharmaceuticals USD 870.94M 67.38M 2025-03
Agios Pharmaceuticals USD 968.62M 3.02M 2025-03
Alnylam Pharmaceuticals USD 3.64B 375.44M 2025-06
Amgen USD 26.93B 2.1B 2025-03
Bayer EUR 34.83B 388M 2025-03
Biogen USD 7.97B 341.7M 2025-06
BioMarin Pharmaceutical USD 3.47B 235.48M 2025-03
Gilead Sciences USD 19.17B 4.39B 2024-12
Incyte USD 3.64B 411.91M 2025-06
Insmed USD 1.4B 218.97M 2025-03
Ionis Pharmaceuticals USD 2.58B 158.22M 2025-06
Moderna USD 6.77B 1.33B 2025-03
Neurocrine Biosciences USD 1.75B 111M 2025-06
PTC Therapeutics USD 2.32B 950.88M 2025-03
Regeneron Pharmaceuticals USD 17.57B 9.64B 2025-03
Roche Holding CHF 40.04B 6.41B 2024-12
Sanofi 42.59B 12.51B 2024-12
Sarepta Therapeutics USD 2.43B 640.93M 2025-03
Ultragenyx Pharmaceutical USD 817.12M 17.52M 2024-12
United Therapeutics USD 3.83B 112.9M 2025-06
Vertex Pharmaceuticals USD 9.6B 207.7M 2024-12


BioMarin Pharmaceutical Umlaufvermögen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.